|
Market Closed -
Nasdaq
16:15:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 117.73 USD | +4.50% |
|
-2.32% | +47.58% |
Main features
| US74347R2141 | Fees | 1.19% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 141.28M | Replication Method | Indirect (Synthetic) |
| Number of securities | - | AuM evolution | - | Date of creation | 2010-04-06 |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIB | Delayed | |
CBOE
| BIB | Real-time |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Biotechnology, Pharmaceuticals |
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$117.73 | +4.50% | 5,878 |
| 26-11-05 | US$112.66 | -9.95% | 35,994 |
| 26-11-04 | US$125.11 | +5.33% | 8,336 |
| 26-11-03 | US$118.78 | +1.43% | 5,764 |
| 26-11-02 | US$117.10 | -2.85% | 8,053 |
- Stock Market
- ETF
- BIB ETF
Select your edition
All financial news and data tailored to specific country editions






















